These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 10935500)
21. TEL/AML1 shows dominant-negative effects over TEL as well as AML1. Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275 [TBL] [Abstract][Full Text] [Related]
22. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Okuda K; Golub TR; Gilliland DG; Griffin JD Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688 [TBL] [Abstract][Full Text] [Related]
23. Tel induces a G1 arrest and suppresses Ras-induced transformation. Rompaey LV; Potter M; Adams C; Grosveld G Oncogene; 2000 Nov; 19(46):5244-50. PubMed ID: 11077441 [TBL] [Abstract][Full Text] [Related]
24. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Fenrick R; Amann JM; Lutterbach B; Wang L; Westendorf JJ; Downing JR; Hiebert SW Mol Cell Biol; 1999 Oct; 19(10):6566-74. PubMed ID: 10490596 [TBL] [Abstract][Full Text] [Related]
25. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Golub TR; Goga A; Barker GF; Afar DE; McLaughlin J; Bohlander SK; Rowley JD; Witte ON; Gilliland DG Mol Cell Biol; 1996 Aug; 16(8):4107-16. PubMed ID: 8754809 [TBL] [Abstract][Full Text] [Related]
26. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Wang LC; Swat W; Fujiwara Y; Davidson L; Visvader J; Kuo F; Alt FW; Gilliland DG; Golub TR; Orkin SH Genes Dev; 1998 Aug; 12(15):2392-402. PubMed ID: 9694803 [TBL] [Abstract][Full Text] [Related]
27. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells. Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001 [TBL] [Abstract][Full Text] [Related]
28. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. Chakrabarti SR; Sood R; Ganguly S; Bohlander S; Shen Z; Nucifora G Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7467-72. PubMed ID: 10377438 [TBL] [Abstract][Full Text] [Related]
29. Ets factors and regulation of the extracellular matrix. Trojanowska M Oncogene; 2000 Dec; 19(55):6464-71. PubMed ID: 11175362 [TBL] [Abstract][Full Text] [Related]
30. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells. Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908 [TBL] [Abstract][Full Text] [Related]
31. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Buijs A; Sherr S; van Baal S; van Bezouw S; van der Plas D; Geurts van Kessel A; Riegman P; Lekanne Deprez R; Zwarthoff E; Hagemeijer A Oncogene; 1995 Apr; 10(8):1511-9. PubMed ID: 7731705 [TBL] [Abstract][Full Text] [Related]
32. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation. Kawagoe H; Potter M; Ellis J; Grosveld GC Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392 [TBL] [Abstract][Full Text] [Related]
33. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. Kim CA; Phillips ML; Kim W; Gingery M; Tran HH; Robinson MA; Faham S; Bowie JU EMBO J; 2001 Aug; 20(15):4173-82. PubMed ID: 11483520 [TBL] [Abstract][Full Text] [Related]
34. TEL gene rearrangements in myeloid malignancy. Golub TR Hematol Oncol Clin North Am; 1997 Dec; 11(6):1207-20. PubMed ID: 9443053 [TBL] [Abstract][Full Text] [Related]
35. TEL/ARG induces cytoskeletal abnormalities in 293T cells. Palmi C; Fazio G; Cassetti A; Aloisi A; Villa A; Biondi A; Cazzaniga G Cancer Lett; 2006 Sep; 241(1):79-86. PubMed ID: 16310306 [TBL] [Abstract][Full Text] [Related]
37. Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13). Nakamura F; Nakamura Y; Maki K; Sato Y; Mitani K Cancer Res; 2005 Aug; 65(15):6612-21. PubMed ID: 16061641 [TBL] [Abstract][Full Text] [Related]
38. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Kim DH; Moldwin RL; Vignon C; Bohlander SK; Suto Y; Giordano L; Gupta R; Fears S; Nucifora G; Rowley JD Blood; 1996 Aug; 88(3):785-94. PubMed ID: 8704231 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins. Heibert SW; Lutterbach B; Durst K; Wang L; Linggi B; Wu S; Wood L; Amann J; King D; Hou Y Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S31-4. PubMed ID: 11587363 [TBL] [Abstract][Full Text] [Related]
40. The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6). Boccuni P; MacGrogan D; Scandura JM; Nimer SD J Biol Chem; 2003 Apr; 278(17):15412-20. PubMed ID: 12588862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]